This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Friday, December 31, 2010
Cardiac calls spike with snowfall (Canada)
Thursday, December 30, 2010
Diabetes growing burden on health system, says advocacy group (Canada)
The growing prevalence of diabetes among Canadians threatens to not only become a health crisis for this country, but also an economic one, says a leading organization in the fight against the disease. The Canadian Diabetes Association says diabetes costs the Canadian health system $12.2 billion in 2000 and predicts that figure will rise to $16.9 billion by 2020
Wednesday, December 29, 2010
Why exercise helps the heart
Poor response to anti-anemia drug predicts higher risk of heart disease or death
Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found. The results suggest that testing such patients' responsiveness to the drug and keeping blood iron levels a little low might reduce their risk, said Dr. Robert Toto, professor of internal medicine and clinical sciences and a senior author of the study, which appeared in the New England Journal of Medicine. "These patients required higher doses and ended up having lower hemoglobin anyway," Dr. Toto said. "The results of this study might lead us in directions that can help." The results were an unexpected finding of a study on darbepoetin alpha, which stimulates the production of red blood cells to counteract anemia. The drug, manufactured by Amgen, is sold under the name Aranesp. The study, called the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) showed that darbepoetin alpha works no better than a placebo for improving cardiovascular and kidney outcomes, but it did lower the risk for blood transfusion and resulted in modest improvement in patient-reported outcomes among people with diabetes, kidney disease and anemia. However, people receiving darbepoetin alpha had nearly a twofold higher risk for stroke. Cancer deaths were also higher among people receiving the drug - EurekAlert
Smokers to get free nicotine patches (UK)
Monday, December 27, 2010
New hope for atrial fibrillation patients (Canada)
Friday, December 24, 2010
The Patient Channel works with the American Heart Association and the American Stroke Association to fight cardiovascular disease in hospitals
Psoriasis, Heart Disease, and Diabetes: What's the Link?
Why the day after Christmas is hazardous to your heart (USA)
Stroke news - Winter 2010 (UK)
Smokers and fat patients thrown off NHS waiting lists (UK)
Wood stoves in Germany shortens lives
America's stroke belt partially fueled by fried fish
How exercise grows a healthy heart
Older people who eat healthy diets 'lead longer lives'
Big Bike teams making their community heart-safe! (Saskatchewan)
Thursday, December 23, 2010
Surgery offers new start - Chris Daly, Guinness World Record holder (Saskatchewan, Canada)
Wednesday, December 22, 2010
Abbott Laboratories recalls millions of diabetes testing strips over incorrect readings
The U.S. Food and Drug Administration has said that Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings. The testing strips are used to help diabetes patients check their blood sugar levels. But the FDA says the products being recalled by Abbott can give inaccurately low measurements. As a result, patients may try to raise their blood sugar levels unnecessarily or fail to detect dangerously high blood sugar levels. The FDA said the problems are caused by a defect that limits the amount of blood absorbed by each strip. North Chicago-based Abbott is recalling 359 lots marketed under a half-dozen brand names, including: Precision Xceed Pro, Precision Xtra, Medisense Optium, Optium, OptiumEZ and ReliOn Ultima
Tuesday, December 21, 2010
Dairy fat may cut Type 2 diabetes risk: study
Monday, December 20, 2010
Friday, December 17, 2010
Heart saver that clears arteries then dissolves (UK)
"A heart patient has become the first in London to be fitted with a device that opens up a blocked artery and then disappears. Medics at King's College Hospital fitted the 67-year-old typesetter from Kent with bioresorbable vascular scaffolds (BVS). They are being hailed as a big step forward in the battle against coronary heart disease. Previously, patients would have been fitted with a metal stent, which opens up the clogged artery, allowing oxygen-rich blood to pass through. But the stent remains in the body and this can lead to complications because it is pressing on the vessel. A BVS does the same job — but it dissolves slowly after the vessel has healed and no longer needs support. It is made of polyactide, a material used in implants such as dissolvable sutures for wounds."
Beetroot juice could help people live more active lives
AstraZeneca shares hit by US drug approval delay
"Shares in AstraZeneca dropped 5% in early London trading after US regulators further delayed approval of its heart drug Brilinta. Markets had expected the UK drugmaker's blood thinner to get the go-ahead. The US Food and Drug Administration (FDA) said it wanted further analysis of existing drugs studies, although no further studies are needed. Brilinta, which is already approved in Europe, is expected to reach $2bn (£1.3bn) sales in the US once approved. The FDA had already postponed its review of the heart drug since September after patients in a North American trial of the drug failed to show significant benefits. AstraZeneca is hoping Brilinta will challenge Plavix produced by rivals Bristol-Myers Squibb and Sanofi-Aventis, which is the second best-selling drug in the world with over $9.5bn sales last year. The UK company is about to see patents on some of its other major brands expire, including schizophrenia drug Seroquel and heartburn relief Nexium" - BBC
Monday, December 13, 2010
Alcohol consumption linked to coronary artery disease in Chinese men
Legacy's cardiac, pulmonary rehab programs receive national accreditation (USA)
The cardiac and pulmonary rehabilitation programs at Legacy Good Samaritan Medical Center (Oregon) and Legacy Meridian Park Medical Center recently earned national accreditation from the American Association of Cardiovascular and Pulmonary Rehabilitation. Certification recognizes those programs that are rigorously reviewed by a national board and found to meet strict national standards and guidelines for patient safety and treatment protocols. The cardiac and pulmonary teams at both hospitals include registered nurses, exercise physiologists, physical therapists, dietitians and medical assistants. The staffs know that accomplishing the recertification of their programs by AACVPR sends a powerful message that they provide the highest quality programs to serve the needs of their patients and their families. Good Samaritan Medical Center and Meridian Park Medical Center offer comprehensive services, including cardiac rehab (inpatient); cardiac and pulmonary rehab (outpatient); wellness programs in the hospitals; and partnerships with health clubs in the community - Oregon Live
'Ticking time-bomb' of United Arab Emirates diabetes
"Experts say the high rate of diabetes in the UEA is because in just a couple of generations, the population has transformed from tribes on the move, to people more used to a life based around shopping malls. It may be an oil-rich country, but if problems with diabetes and other cardiovascular diseases are not tackled, healthcare spending is predicted to spiral. The BBC's Katy Watson reports from Abu Dhabi:
Pfizer pulls hypertension drug Thelin off the markets and ends studies because of liver damage
Sunday, December 12, 2010
Lifesaving lessons offered at Heathrow airport (UK)
Passengers travelling through Heathrow are being given the opportunity to take a five-minute lifesaving skills lesson. London Ambulance Service staff are offering to show members of the public and airport staff how to respond if they see someone suffering a cardiac arrest. The demonstration includes instruction on how to perform CPR and how to use a defibrillator, a machine that can deliver a shock to restart a patient's heart. The training is part of an initiative to provide defibrillators in public spaces which can be used by members of the public until emergency services arrive
Thursday, December 9, 2010
Big difference in heart failure mortality rates shown by largest ever audit in England and Wales
The third report from the National Heart Failure Audit, which analysed more than 21,000 patient records, suggests about 32 per cent of heart failure patients will die within a year of their hospital admission. However the mortality rate falls to 23 per cent for those are seen by a cardiologist or have access to specialist heart failure services. In-patient mortality is also twice as likely for a heart failure patient if they are on a non cardiac ward; at 12 per cent compared to 6 per cent. Today's audit report presents the most robust findings to date about patient mortality for heart failure – which affects about one in every hundred people in the UK and rises to one in 15 for those aged 75 and over. Run jointly by The NHS Information Centre and the British Society for Heart Failure and commissioned by the Healthcare Quality Improvement Partnership (HQIP), the report focuses on the care of patients with unscheduled admissions to hospital for heart failure in England and Wales between April 2009 and March 2010
Wednesday, December 8, 2010
British Heart Foundation - new website
Tuesday, December 7, 2010
Heart stenting on the rise in Canada
The number of Canadians having blocked heart arteries opened with a non-surgical procedure more than doubled between 1994 and 2005, mirroring trends seen in the U.S., Europe and elsewhere, according to a new study. It is unclear whether the increase reflects appropriate use of the procedure, called angioplasty, or has been "too great" - or possibly not great enough - said lead researcher Dr. Ansar Hassan, of Saint John Regional Hospital in Canada. During angioplasty, a balloon-tipped catheter is threaded into a clogged artery to push blockages aside; usually a small mesh tube called a stent is placed in the artery to help keep it from re-narrowing. For the study, published in the American Heart Journal, Hassan and his colleagues looked at government data on all cases of angioplasty and heart bypass surgery - another option for treating blocked heart arteries - across Canada - Reuters
High salt levels in ready made Sunday lunch warning (UK)
Half of Europeans are overweight, a report shows
Small daily aspirin dose 'cuts cancer risk' (UK)
Sunday, December 5, 2010
Peter Guzak obituary
Elsie Asher obituary
Saturday, December 4, 2010
Healthy People 2020 (USA)
* Identify nationwide health improvement priorities.
* Increase public awareness and understanding of the determinants of health, disease, and disability and the opportunities for progress.
* Provide measurable objectives and goals that are applicable at the national, State, and local levels.
* Engage multiple sectors to take actions to strengthen policies and improve practices that are driven by the best available evidence and knowledge.
* Identify critical research, evaluation, and data collection needs.
Wednesday, December 1, 2010
Eating vegetables, fruits as children linked to healthier arteries as adults
Fire Walk in London for The Stroke Association
Leading causes of death in Canada in 2007
From Statistics Canada - "Cancer and heart disease, the two leading causes of death for Canadians, were responsible for just over one-half (51%) of the 235,217 deaths in Canada in 2007. Cancer accounted for 30% of deaths, and heart disease, 22%. Stroke, in third place, accounted for 6%. The proportion from cancer was up slightly from 2000, while the proportion from both heart disease and stroke declined. Ranked in order, the other seven leading causes of death were chronic lower respiratory diseases, accidents, diabetes, Alzheimer's disease, influenza and pneumonia, kidney disease and suicide. These 10 leading causes accounted for 77% of all deaths in 2007, down from 80% in 2000. The list has been identical since 2000, but the ranking has changed slightly. In 2000, suicide and kidney disease were ninth and tenth, respectively. By 2007, they had switched places"
Tiny blood vessels show pollution, heart disease link
Snoring, sleep problems may signal heart risk
Study links older depression drugs to heart risk (UK)
Subscribe to:
Posts (Atom)